Share on StockTwits

Analysts’ upgrades for Tuesday, August 26th:

Bioquell plc (LON:BQE) was upgraded by analysts at Investec to an add rating. They currently have GBX 98 ($1.62) price target on the stock, down from their previous price target of GBX 133 ($2.20).

Bioquell plc (LON:BQE) was upgraded by analysts at N+1 Singer to a buy rating. The firm currently has GBX 112 ($1.85) price target on the stock.

Greene King plc (LON:GNK) was upgraded by analysts at Numis Securities Ltd to a buy rating. They currently have GBX 975 ($16.13) target price on the stock.

Kazakhmys plc (LON:KAZ) was upgraded by analysts at Canaccord Genuity to a hold rating. Canaccord Genuity currently has GBX 300 ($4.96) target price on the stock, up from their previous target price of GBX 295 ($4.88).

Liquor Stores N.A. (TSE:LIQ) was upgraded by analysts at National Bank Financial to a sector perform rating.

Macerich (NYSE:MAC) was upgraded by analysts at BMO Capital Markets from a market perform rating to an outperform rating.

Melco Crown Entertainment Ltd (NASDAQ:MPEL) was upgraded by analysts at Morgan Stanley to an overweight rating.

SandRidge Permian Trust (NYSE:PER) was upgraded by analysts at Raymond James from a market perform rating to an outperform rating.

Phoenix Group Holdings (LON:PHNX) was upgraded by analysts at Barclays to an equal weight rating. They currently have GBX 713 ($11.80) target price on the stock.

Plexus Holdings PLC (LON:POS) was upgraded by analysts at Numis Securities Ltd to a buy rating. They currently have GBX 372 ($6.16) price target on the stock, up from their previous price target of GBX 364 ($6.02).

Synthomer PLC (LON:SYNT) was upgraded by analysts at Deutsche Bank to a buy rating. Deutsche Bank currently has GBX 260 ($4.30) target price on the stock, up from their previous target price of GBX 225 ($3.72).

Receive News & Ratings for Bioquell plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioquell plc and related companies with Analyst Ratings Network's FREE daily email newsletter.